期刊文献+

甲状旁腺激素相关蛋白与肺癌及乳腺癌骨转移的相关研究 被引量:5

下载PDF
导出
摘要 目的通过放射免疫学(RIA)的方法来研究甲状旁腺激素相关蛋白(PTHrP)与实体瘤骨转移的相关性,为临床工作中肿瘤骨转移的诊断与治疗提供新的途径。方法 57例患者中,男28例,女29例;年龄33~76岁,平均年龄61岁。根据CSCO最新发布的2007版《实体瘤(肺癌,乳腺癌)骨转移临床诊疗专家共识》中提出的骨转移的诊断方法对肿瘤患者进行分组。A组为伴发骨转移的肿瘤患者28例;B组为无骨转移的肿瘤患者29例。C组为正常对照31例,为同期健康体检者,年龄35~75岁,平均年龄64岁(均排除肿瘤及甲状旁腺疾病)。通过放射免疫分析法检测血浆中PTHrP水平。结果 A、B、C组PTHrP水平分别为(48±5)pg/100μl,(40±4)pg/100μl,(37±6)pg/100μl。A组的PTHrP值均高于B组与C组,3组间比较,差异有统计学意义(P<0.05)。结论肺癌、乳腺癌骨转移瘤患者体内PTHrP水平明显高于无骨转移及健康者,提示PTHrP与肿瘤骨转移具有一定相关性。
出处 《河北医药》 CAS 2010年第14期1854-1856,共3页 Hebei Medical Journal
  • 相关文献

参考文献13

  • 1Berenson JR,Rajdev L,Broder M.Pathophysiology of bone metastases.Cancer Biol Ther,2006,5:1078-1081.
  • 2Akino K,Ohtsuru A,Kanda K,et al.Parathyroid hormone-related peptide is a potent angiogenic factor.Endorinoligy,2000,141:4313.
  • 3Strewlwer GJ.Mechanisms of disease:the physiology of parathyroid hormone-related protein.N Engl J Med,2000,342:177-185.
  • 4Kumari R,Robertson JF,Watson SA.Nuclear targeting of a midre-gion PTHrP fragment is necessary for stimulating growth in breast cancer cells.Int J Cancer,2006,119:49-59.
  • 5Mau E,Whetstone H,Yu C,et al.PTHrP regulates growth plate chondrocyte differentiation and proliferation in a Gli3 dependent manner utilizing hedgehog ligand dependent and independent mechanisms.Dev Biol,2007,305:28-39.
  • 6Yoneda T,Hiraga T.Crosstalk between cancer cells and bone microenvironment in bone metastasis.Biochem Biophys Res Commun,2005,328:679-687.
  • 7Liao J,McCauley LK.Skeletal Metastasis:Established and Emerging Roles of Parathyroid Hormone Related Protein (PTHrP).Cancer Metastasis Rev,2006,25:559-571.
  • 8王涛,宋三泰,江泽飞,卞寿庚,王雅杰,李丽庆,朱军.伊班膦酸治疗恶性肿瘤性高钙血症的临床研究[J].中华肿瘤杂志,2004,26(12):739-741. 被引量:25
  • 9Shen X,Falzon M.PTH-related proteinmodulates PC-3 prostatecaner cell adhesionand integrin subunit profile.Mol Cell Endocrinol,2003,199:165-177.
  • 10El-Hashash AH,Esbrit P,Kimber SJ.PTHrP promotes murine secondary trophoblast giant cell differentiation through induction of endocycle,upregulation of giant-cell-promoting transcription factors and suppression of other trophoblast cell types.Differentiation,2005,73:154-174.

二级参考文献4

  • 1Dooley M,Balfour JA.Ibandronate[].Drugs.1999
  • 2Pecherstorfer M,Herrmann Z,Body JJ,et al.Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy[].Journal of Clinical Oncology.1996
  • 3Body JJ.Current and future directions in medical therapy:hypercalcemia[].Cancer.2000
  • 4Ralston SH,Thiebaud D,Herrmann Z,et al.Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia[].British Journal of Cancer.1997

共引文献24

同被引文献44

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部